Pharma Mar, S.A. (OTCMKTS:PHMMF – Get Free Report) hit a new 52-week high on Monday . The stock traded as high as $105.60 and last traded at $105.60, with a volume of 114 shares changing hands. The stock had previously closed at $95.79.
Pharma Mar Trading Up 10.2 %
The business’s 50 day simple moving average is $88.32 and its 200-day simple moving average is $71.25. The company has a quick ratio of 2.01, a current ratio of 2.55 and a debt-to-equity ratio of 0.14.
Pharma Mar Company Profile
Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.
See Also
- Five stocks we like better than Pharma Mar
- What Are Earnings Reports?
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- Should You Invest in Penny Stocks?
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- What Are the FAANG Stocks and Are They Good Investments?
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Receive News & Ratings for Pharma Mar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma Mar and related companies with MarketBeat.com's FREE daily email newsletter.
